跳至主要内容
临床试验/NCT00733200
NCT00733200已完成不适用

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Huazhong University of Science and Technology0 个研究点开始时间: 2008年8月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
主要终点
On multivariate analysis, prognostic factors significantly impacted on long-term survival were UICC tumor stage and histopathologic grade.

研究概览

简要总结

The investigators conducted a prospective study to determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in 138 patients with hilar cholangiocarcinoma. In selected patients, minor liver resection was a good treatment.

详细描述

Objective

To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC).

Summary Background Data: For HC treated with hepatectomy, the extent of liver resection remains controversial despite extensive studies.

Methods: From January 2000 to December 2007, we prospectively studied patients who received surgical treatment for HC. Of the 187 patients who were surgically treated, 138 (73.8%) underwent resection with a curative intent. Minor hepatectomy was carried out in 93 patients who had Bismuth-Corlette types I, II and III HC without hepatic artery/portal vein invasion; and major hepatectomy in 45 patients who had type III HC with hepatic artery/portal vein invasion, or type IV HC.

研究设计

研究类型
Interventional

入排标准

年龄范围
26 Years 至 72 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Criteria for resectability were absence of peritoneal or liver metastases, tumor extension to beyond secondary biliary branches bilaterally, tumor extension to secondary portal venous branches bilaterally

排除标准

  • not in accordance with the above criteria

结局指标

主要结局

On multivariate analysis, prognostic factors significantly impacted on long-term survival were UICC tumor stage and histopathologic grade.

次要结局

未报告次要终点

研究者

相似试验

Surgical Treatment of Hilar Cholangiocarcinoma:... | 临床试验